CLINICAL_TRIALS
trial_result
· 2025-05-21
Clinical Trial Update: Phase II Study of Combined Chemotherapy With Arsenic Trioxide in Stage 4/M Neuroblastoma [Phase 2]
Summary
Phase II clinical trial evaluating arsenic trioxide in combination with chemotherapy for stage 4/M neuroblastoma; results posted on 2025-05-21.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Yang Li | Conditions: Neuroblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-05-21